NCT01584492 Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children Status COMPLETED Phase PHASE2
NCT01583296 LUCHAR - Latinos Using Counseling for Help With Asthma and Anxiety Reduction Status COMPLETED Phase NA
NCT01582503 A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA) Status COMPLETED Phase PHASE2
NCT01581177 Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation Status COMPLETED Phase PHASE2
NCT01578824 Assessment Of Vitamin D Role In The Pathogenesis Of Asthma In Vitamin D Resistent Patients Status COMPLETED Phase NA
NCT01577953 Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma Status COMPLETED Phase PHASE1
NCT01577628 Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis Status TERMINATED Phase NA
NCT01577082 Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients Status COMPLETED Phase PHASE3
NCT01576718 A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications Status COMPLETED Phase PHASE2
NCT01573767 Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Status COMPLETED Phase PHASE2
NCT01573624 Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma Status COMPLETED Phase PHASE2
NCT01568762 To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma Status COMPLETED Phase PHASE1
NCT01567280 International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison) Status COMPLETED Phase N/A
NCT01566149 Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212) Status COMPLETED Phase PHASE3
NCT01563042 A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers Status COMPLETED Phase PHASE1